Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: A meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 4, 2013, Pages 653-659

  Ni, Jia Yan ^a   Liu, Shan Shan ^b   Xu, Lin Feng ^a   Sun, Hong Liang ^a   Chen, Yao Ting ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Percutaneous radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TRANSARTERIAL CHEMOEMBOLIZATION;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876411123     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1369-x     Document Type: Article

References (33)

1. Bruix J, Sherman M (2005) Practice guidelines committee, American association for the study of liver diseases management of hepatocellular carcinoma. Hepatology 42:1208-1236
2. Bruix J, Sala M, Llovet JM (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127:S179-S185
3. Buscarini L, Buscarini E, Di Stasi M et al (1999) Percutaneous radiofrequency thermal ablation combined with transcatheter arterial chemoembolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 20:47-53
4. Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocelluar carcinoma. Ann Surg 243:321-328
5. Cho YK, Kim JK, Kim MY et al (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453-459
6. Egger M, Smith GD, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
7. Ferenci P, Fried M, Labrecque D et al (2010) Hepatocellular carcinoma(HCC): a global perspective. J Clin Gastroenterol 44:239-245
8. Germani G, Pleguezuelo M, Gurusamy K et al (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol 52:380-388
9. Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928
10. Jarnagin W, Chapman WC, Curley S et al (2010) Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxf) 12:302-310
11. Kim KM, Kim JH, Park IS et al (2009) Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol 24:806-814
12. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN (2012) Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 81:e189-e193
13. Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H (2007) Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 27:1749-1751
14. Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214:761-768
15. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442
16. Marelli L, Shusang V, Buscombe JR et al (2009) Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unrescetable hepatocellular cancer. J Nucl Med 50:871-877
17. Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K (2010) Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 116:5452-5460
18. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153-156
19. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS (2012) Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 262:689-700
20. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J (2000) Transarterial chemoembolization for inoperable hepatocellular carcinoma and post resection intrahepatic recurrence. J Oncol Surg 73:109-114
21. Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS (2005) Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 52:1403-1407
22. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K (2009) Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 252:905-913
23. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 103:1201-1209
24. Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS (2005) Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation. Ai Zheng 24:827-833
25. Wang W, Shi J, Xie WF et al (2010) Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 30:741-749
26. Wang N, Guan Q, Wang K et al (2011) TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis. Med Oncol 28:1038-1043
27. Xu L, Li P, Chen MS, Pang XH, Gao HJ, Peng ZW, Liang HH, Zhang YJ, Li JQ (2008) Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy. Zhonghua Wai Ke Za Zhi 46:1617-1620
28. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7:448-458
29. Yang P, Liang M, Zhang Y, Shen B (2008) Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Ther 25:787-794
30. Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, Wu JY, Dai Y, Yan K (2009) Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 39:231-240
31. Yuen MF, Chan AO, Wong BC et al (2003) Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 98:1181-1185
32. Zhang Z, Wu M, Chen H, Chen D, He J (2002) Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 40:826-829
33. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH (2011) Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors. Zhonghua Yi Xue Za Zhi 91:1167-1172